98%
921
2 minutes
20
Background And Objectives: Surveillance after gastric endoscopic submucosal dissection (ESD) is crucial due to the high risk of metachronous gastric lesions (MGL), although this risk may differ between patients. We sought to validate the FAMISH score - a prediction score to estimate MGL risk after gastric ESD - within a multicentric framework.
Materials And Methods: Performance measures of the FAMISH score were assessed in a retrospective analysis of a multicenter cohort, which included consecutive adult patients undergoing ESD for a primary gastric superficial lesion at 15 international centers, with a minimum endoscopic follow-up of at least 3 years.
Results: A total of 855 individuals were included, with 20% of them considered low-risk according to the FAMISH score. After a mean follow-up time of 5 years (SD ± 2 years), 168 patients (19.6%) developed MGL. At 3 years of follow-up, the score achieved 90.4% sensitivity and 93.9% NPV. At 5 years follow-up, the score achieved 89.1% sensitivity and 85.3% NPV. The FAMISH risk score achieved a fair diagnostic accuracy with an AUC of 0.618 at 3 years ( < 0.001) and 0.597 ( = 0.006) at 5 years of follow-up. The progression to MGL at 5 years of follow-up was significantly lower for the low-risk group (9.6% vs. 18.2%, = 0.029).
Conclusions: The FAMISH score achieved an acceptable diagnostic accuracy in a multicentric validation cohort from Western countries. This score is a useful tool to identify patients with low risk for MGL allowing to safely extend surveillance intervals and reduce the burden of care.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/00365521.2025.2522464 | DOI Listing |
Scand J Gastroenterol
June 2025
Department of Gastroenterology, Portuguese Institute of Oncology of Porto (IPO Porto), Porto, Portugal.
Background And Objectives: Surveillance after gastric endoscopic submucosal dissection (ESD) is crucial due to the high risk of metachronous gastric lesions (MGL), although this risk may differ between patients. We sought to validate the FAMISH score - a prediction score to estimate MGL risk after gastric ESD - within a multicentric framework.
Materials And Methods: Performance measures of the FAMISH score were assessed in a retrospective analysis of a multicenter cohort, which included consecutive adult patients undergoing ESD for a primary gastric superficial lesion at 15 international centers, with a minimum endoscopic follow-up of at least 3 years.
Eur J Gastroenterol Hepatol
January 2024
Endoscopy Room, Xingtai Third Hospital.
Objective: To externally validate the robustness of the FAMISH predicting score designed to estimate the risk of metachronous gastric lesions (MGLs) after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC).
Methods: This multicenter, retrospective study included 618 patients with EGC who underwent curative ESD at two tertiary referral teaching hospitals between January 2014 and December 2019. FAMISH score was a composite indicator of age, sex, family history, corpus intestinal metaplasia, synchronous lesions, and H.
Endoscopy
October 2023
Gastroenterology Department, RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) and Porto Comprehensive Cancer Centre (Porto.CCC), Porto, Portugal.
Background: Surveillance after gastric endoscopic submucosal dissection (ESD) is recommended for all patients owing to the persistent risk of metachronous gastric lesions (MGLs). We developed and validated a prediction score to estimate MGL risk after ESD for early neoplastic gastric lesions, to define an individualized and cost-saving approach.
Methods: Clinical predictors and a risk score were derived from meta-analysis data.